SOTERA HEALTH COMPANY Cash and Restricted Cash
SOTERA HEALTH COMPANY (SHC) had Cash and Restricted Cash of $356.73 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $356.73M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $315.94M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $346.46M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $301.03M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $356.73M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $315.94M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $346.46M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $301.03M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $334.27M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $306.08M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $278.87M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $308.48M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $247.76M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $262.82M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $301.65M 10-K · filed 2026-02-24 |
| 2023-09-30 | $252.53M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $270.49M 10-Q · filed 2024-08-05 |
| 2023-03-31 | $660.18M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $396.29M 10-K · filed 2026-02-24 |
| 2022-09-30 | $164.96M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $140.62M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $121.45M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $106.92M 10-K · filed 2025-02-27 |
| 2021-09-30 | $114.92M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $156.22M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $108.02M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $102.45M 10-K · filed 2024-02-27 |
| 2020-09-30 | $108.44M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $86.36M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $105.19M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $63.02M 10-K · filed 2023-02-28 |
| 2018-12-31 | $96.79M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |